Price
Financials
Standalone, Rs crore| Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.71 | 7.07 | 8.02 | 3.26 | 2.28 | 2.76 | 2.73 | 2.08 | 2.13 | 2.33 | 2.05 | 2.13 |
| Expenses | 2.14 | 5.40 | 6.07 | 2.81 | 2.46 | 2.50 | 2.38 | 1.04 | 1.59 | 1.82 | 1.79 | 2.00 |
| Operating Profit | 0.57 | 1.67 | 1.95 | 0.45 | -0.18 | 0.26 | 0.35 | 1.04 | 0.54 | 0.51 | 0.26 | 0.13 |
| OPM % | 21.03% | 23.62% | 24.31% | 13.80% | -7.89% | 9.42% | 12.82% | 50.00% | 25.35% | 21.89% | 12.68% | 6.10% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.24 | 0.00 | 0.00 | 0.29 | 0.00 |
| Interest | 0.05 | 0.30 | 0.24 | 0.33 | 0.48 | 0.51 | 0.11 | 0.28 | 0.05 | 0.03 | 0.01 | 0.01 |
| Depreciation | 0.23 | 0.29 | 0.28 | 0.30 | 0.33 | 0.34 | 0.33 | 0.29 | 0.28 | 0.28 | 0.28 | 0.29 |
| Profit before tax | 0.29 | 1.08 | 1.43 | -0.18 | -0.98 | -0.59 | -0.09 | 0.71 | 0.21 | 0.20 | 0.26 | -0.17 |
| Tax % | 24.14% | 27.78% | 25.17% | -22.22% | 0.00% | 0.00% | 0.00% | 0.00% | 23.81% | -35.00% | 26.92% | -17.65% |
| Net Profit | 0.23 | 0.79 | 1.07 | -0.13 | -0.97 | -0.59 | -0.09 | 0.71 | 0.15 | 0.27 | 0.20 | -0.13 |
| EPS in Rs | 0.26 | 0.91 | 1.23 | -0.15 | -1.11 | -0.68 | -0.10 | 0.82 | 0.17 | 0.31 | 0.23 | -0.15 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.79 | 5.26 | 6.10 | 9.78 | 11.28 | 5.04 | 4.81 | 4.45 | 4.19 |
| Expenses | 2.17 | 4.06 | 4.84 | 7.54 | 8.81 | 4.95 | 4.59 | 3.52 | 3.50 |
| Operating Profit | 0.62 | 1.20 | 1.26 | 2.24 | 2.47 | 0.09 | 0.22 | 0.93 | 0.69 |
| OPM % | 22.22% | 22.81% | 20.66% | 22.90% | 21.90% | 1.79% | 4.57% | 20.90% | 16.47% |
| Other Income | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 1.40 | 0.13 | 0.00 |
| Interest | 0.16 | 0.14 | 0.18 | 0.35 | 0.60 | 0.99 | 0.38 | 0.09 | 0.02 |
| Depreciation | 0.13 | 0.35 | 0.42 | 0.52 | 0.59 | 0.66 | 0.62 | 0.56 | 0.57 |
| Profit before tax | 0.36 | 0.72 | 0.66 | 1.37 | 1.28 | -1.56 | 0.62 | 0.41 | 0.10 |
| Tax % | 25.00% | 26.39% | 28.79% | 26.28% | 28.12% | 0.00% | 0.00% | -2.44% | 30.00% |
| Net Profit | 0.26 | 0.53 | 0.47 | 1.01 | 0.93 | -1.56 | 0.62 | 0.42 | 0.06 |
| EPS in Rs | 0.44 | 0.61 | 0.54 | 1.16 | 1.07 | -1.79 | 0.71 | 0.48 | 0.07 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | -16% | -6% | -6% | ||
| Compounded Profit Growth | % | -43% | 27% | -80% | ||
| Stock Price CAGR | % | -17% | -31% | -57% | ||
| Return on Equity | % | -2% | -1% | 1% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.93 | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 | 4.33 | 8.64 |
| Reserves | 0.40 | 3.73 | 4.21 | 5.22 | 6.15 | 4.59 | 5.21 | 5.62 | 5.50 |
| Borrowings | 1.88 | 0.90 | 1.76 | 4.04 | 5.15 | 6.40 | 3.48 | 4.07 | 2.06 |
| Other Liabilities | 1.00 | 1.18 | 1.63 | 1.61 | 2.49 | 2.40 | 1.97 | 1.72 | 1.40 |
| Total Liabilities | 6.21 | 10.14 | 11.93 | 15.20 | 18.12 | 17.72 | 14.99 | 15.74 | 17.60 |
| Fixed Assets | 2.06 | 3.28 | 3.47 | 5.24 | 5.75 | 5.39 | 3.99 | 3.51 | 3.27 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.24 | 0.41 | 0.27 | 0.27 |
| Other Assets | 3.91 | 6.62 | 8.22 | 9.72 | 12.13 | 12.09 | 10.59 | 11.96 | 14.06 |
| Total Assets | 6.21 | 10.14 | 11.93 | 15.20 | 18.12 | 17.72 | 14.99 | 15.74 | 17.60 |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.58 | -0.45 | -0.10 | 1.19 | 2.01 | 0.00 | -0.22 | 0.37 | -0.76 |
| Cash from Investing Activity | -1.29 | -1.95 | -0.53 | -2.26 | -1.53 | -0.20 | 1.00 | 0.06 | -0.51 |
| Cash from Financing Activity | 1.57 | 3.51 | 0.85 | 1.71 | 0.16 | -0.23 | -1.59 | 0.58 | 2.12 |
| Net Cash Flow | 0.85 | 1.12 | 0.23 | 0.64 | 0.64 | -0.43 | -0.81 | 1.01 | 0.84 |
| Free Cash Flow | -0.73 | -2.39 | -0.71 | -1.10 | 0.91 | -0.30 | 0.74 | 0.30 | -1.09 |
| CFO/OP | 94% | -32% | 5% | 67% | 95% | 0% | -100% | 40% | -110% |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 149.14 | 126.99 | 199.25 | 148.54 | 136.55 | 359.93 | 356.65 | 431.44 | 532.26 |
| Inventory Days | 167.03 | 233.36 | 158.70 | 68.75 | 191.07 | 458.51 | 255.15 | 490.47 | 306.69 |
| Days Payable | 426.86 | 406.89 | 355.48 | 97.06 | 175.15 | 404.21 | 217.94 | 365.00 | 110.15 |
| Cash Conversion Cycle | -110.69 | -46.54 | 2.47 | 120.23 | 152.47 | 414.23 | 393.86 | 556.91 | 728.79 |
| Working Capital Days | 162.22 | 167.23 | 206.43 | 104.50 | 77.98 | 188.29 | 163.91 | 156.66 | 460.82 |
| ROCE % | 12.14% | 8.72% | 14.40% | 12.87% | -3.68% | -2.68% | 2.81% | 0.79% |
| Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 60.78% | 60.78% | 60.78% | 60.78% | 60.78% | 60.78% | 60.78% | 60.78% | 57.18% | 48.32% | 31.15% | 32.90% |
| Public | 39.22% | 39.22% | 39.22% | 39.22% | 39.23% | 39.22% | 39.21% | 39.22% | 42.82% | 51.68% | 68.84% | 67.10% |
| No. of Shareholders | 143 | 143 | 151 | 157 | 162 | 164 | 159 | 165 | 181 | 246 | 206 | 233 |
Fundamentals
Market Cap₹ 6.26 Cr.
Current Price₹ 7.25
Stock P/E104
Book Value₹ 16.4
ROCE0.79 %
ROE0.50 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-6%
Compounded Profit Growth (TTM)-80%
Standalone figures.
Valuation
Market capRs 3 Cr
Enterprise valueRs 4 Cr
P/E (TTM)7.11x
Price to book0.30x
Price to sales0.67x
EV / EBITDA3.54x
EV / EBIT7.51x
EV / sales0.84x
Price to cash flow8.07x
Earnings yield14.07%
P/E, 3-year average7.95x
P/B, 3-year average0.63x
P/E, 5-year average7.92x
P/B, 5-year average0.67x
Profitability
Operating margin (excl. other income)20.90%
Operating margin (incl. other income)23.82%
EBITDA margin23.82%
Pre-tax margin9.21%
Net profit margin9.44%
ROE4.31%
ROCE3.70%
ROA2.73%
ROE, 3-year average-1.69%
ROCE, 3-year average2.36%
ROA, 3-year average-0.73%
ROE, 5-year average3.08%
ROCE, 5-year average6.87%
ROA, 5-year average2.17%
ROIC (approx.)4.78%
Tax rate-2.44%
Other income / net worth1.31%
Growth
Sales growth (latest year)-7.48%
Profit growth (latest year)-32.26%
Sales CAGR, 3 years-26.66%
Sales CAGR, 5 years-6.11%
Profit CAGR, 3 years-23.28%
Profit CAGR, 5 years-2.22%
Per share
EPS (TTM)Rs 0.97
EPS (latest year)Rs 0.97
EPS, 3-year averageRs -0.40
EPS, 5-year averageRs 0.66
Book value per shareRs 22.96
Sales per shareRs 10.27
Cash flow per shareRs 0.85
Free cash flow per shareRs -2.52
Efficiency
Asset turnover0.28x
Fixed asset turnover1.27x
Inventory turnover1.09x
Inventory days336 days
Debtor days431 days
Debtors turnover0.85x
Creditor days110 days
Cash conversion cycle729 days
Working capital days461 days
Leverage
Total debtRs 4 Cr
Cash and bankRs 3 Cr
Net debtRs 1 Cr
Debt to equity0.41x
Net debt / EBITDA0.73x
Interest coverage5.56x
Owners' fund to total sources63.21%
Debt to assets25.86%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Cash from Investing Activity (latest year)Rs 0 Cr
Cash from Financing Activity (latest year)Rs 1 Cr
Net Cash Flow (latest year)Rs 1 Cr
Free cash flow (latest year)Rs -1 Cr
FCFE (approx.: FCF + change in debt)Rs -0 Cr
Cash from ops / profit, 5 years2.98x
Sales to cash flow12.03x
Statement figures
Net sales (TTM)Rs 4 Cr
Net sales (latest year)Rs 4 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 0 Cr
Tax (latest year)Rs -0 Cr
Net profit (TTM)Rs 0 Cr
Net profit (latest year)Rs 0 Cr
Depreciation (TTM)Rs 1 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 1 Cr
Total expenditure (latest year)Rs 4 Cr
Total income (latest year)Rs 5 Cr
Share capitalRs 4 Cr
ReservesRs 6 Cr
Shareholders' fundsRs 10 Cr
Total assetsRs 16 Cr
Net blockRs 4 Cr
InvestmentsRs 0 Cr
ReceivablesRs 5 Cr
InventoryRs 1 Cr
Other liabilitiesRs 2 Cr
Shares outstanding (crore)0.43
Ownership
Promoter holding32.90% (-27.88 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 7.1 is at the 12th percentile of its own 6.2-year range
(median 10.2, low 5.4, high 29.9).
P/B 0.30 is the lowest in 7.2 years (median 0.79).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 541299 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -14.3% | -2.8% | -11.5 pts |
| 1 month | +9.7% | -6.8% | +16.5 pts |
| 3 months | -29.0% | -7.6% | -21.4 pts |
| 3 years | -68.4% | +14.2% | -82.6 pts |
| 5 years | -59.5% | +27.9% | -87.4 pts |
Red flags
F-score 4 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Mar 2026Sales ₹2 Cr +2.4% vs Mar 2024.
Net loss ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Dr Lal Pathlabs Ltd | 32,737 | 58.2 | 28.0 % |
| Vijaya Diagnostic Centre Ltd | 15,192 | 81.0 | 20.5 % |
| Metropolis Healthcare Ltd | 11,665 | 56.0 | 17.8 % |
| Thyrocare Technologies Ltd | 8,708 | 48.2 | 35.4 % |
| Nephrocare Health Services Ltd | 6,671 | 78.4 | 15.3 % |
| Suraksha Diagnostic Ltd | 1,847 | 51.6 | 17.3 % |
| Krsnaa Diagnostics Ltd | 1,791 | 18.1 | 12.7 % |
| 3B Blackbio DX Ltd | 1,396 | 25.1 | 25.5 % |
| One Global Service Provider Ltd | 1,046 | 14.1 | 87.0 % |
| Health X Platform Ltd | 923 | 0.03 % | |
| Gaudium IVF and Women Health Ltd | 830 | 35.9 | 29.3 % |
| Chandan Healthcare Ltd | 581 | 22.1 | 23.3 % |
| Pramodini Medicare Ltd | 259 | 14.9 | 41.8 % |
| Aspira Pathlab & Diagnostics Ltd | 148 | 2.84 % | |
| Choksi Laboratories Ltd | 132 | 69.2 | 9.44 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd (541299) has a market capitalisation of Rs 6.26 Cr. at the 2026-09-30 close.
What is the P/E ratio of Dr Lalchandani Labs Ltd?
Dr Lalchandani Labs Ltd trades at a P/E of 104 on trailing twelve-month profit, at the 2026-09-30 close.
What were Dr Lalchandani Labs Ltd's latest quarterly results?
In the Mar 2026 quarter, Dr Lalchandani Labs Ltd sales was Rs 2 Cr (+2.4% vs Mar 2024) with a net loss of Rs 0 Cr.